Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours - Wikidata - wikimedia - TriplyDB

Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours

Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours

http://www.wikidata.org/entity/Q57767529

about

Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review).FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.How fibrosis influences imaging and surgical decisions in pancreatic cancer.Surgeons' knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study.Single-scan dual-tracer FLT+FDG PET tumor characterization.18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imag Methodology for quantitative rapid multi-tracer PET tumor characterizations Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.Combined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.Imaging modalities for characterising focal pancreatic lesions.Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors.3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3'-deoxy-3'-[18F] fluorothymidine in patients with lung cancer.The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT.FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT.

P2860

Q26766690-D4D24CC7-6393-4522-A057-47930D61C3D3 Q33727528-85BF1601-EE33-4BB4-A65E-4EEDF4748C7F Q34901401-D90A05CF-6613-4FEA-8C74-7101ACCB7223 Q36291856-8EA2398E-DBCA-434D-8EA6-F57DF3E95099 Q36397177-1491F044-5A42-4544-8CD4-6A20726CE9F1 Q36558260-FC453DC9-AADA-428E-9317-109D31A6C883 Q36727598-2C454DBE-E1C4-4117-A7CB-F762AB995C86 Q37342653-A98E94A2-BF7E-4F29-B211-95FFBE545A19 Q37402623-12C161F7-F383-4C10-9200-F52DF7AC5D2E Q37474422-2602F014-8225-45CE-9914-FF9288D102CB Q38019761-248AD70D-6685-4234-AC27-A2E06F999369 Q38834240-B627390E-80B1-4208-AB95-291906ED5F2A Q38988008-B219BE9D-290D-4F54-8095-49A7C76EFE25 Q39467787-8DC70C45-2AD9-447B-BE23-589DFD098F49 Q41448654-219801AC-F3AC-4DDC-BFB2-EAD8B146ECD2 Q47103576-CF6ECC4D-7D8D-467D-A320-873D4032754B Q49391836-6A43B94D-85E7-4C2D-8FC1-699CB811C5CA Q52953650-BEA88599-BD69-40FB-A274-DF9E1EC9D404 Q52982567-856B9ADA-8038-429F-95C0-C960910BDFBD

P2860

Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours

http://www.wikidata.org/entity/Q57767529

description

im Januar 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 26 January 2012

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2012

@uk

name

Comparison of 3′-deoxy-3′-[18F ...... rization of pancreatic tumours

@en

Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography

@nl

type

label

Comparison of 3′-deoxy-3′-[18F ...... rization of pancreatic tumours

@en

Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography

@nl

prefLabel

Comparison of 3′-deoxy-3′-[18F ...... rization of pancreatic tumours

@en

Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography

@nl

P1433

Q57767529-32CCD4BE-C66D-41D6-9631-BB45D355C7BA

P1476

Q57767529-7AEBE9C4-0DF3-4F54-9414-9F9F3540A952

P2093

Q57767529-12AC7EFE-DD2D-4397-8C5F-4162F5B22DE6

Q57767529-17E13BD0-D5FE-4A94-99DC-D8B33125BF79

Q57767529-27B5BE1B-797A-4A6C-9D27-61BF15AD1A13

Q57767529-3B3147F3-5A86-4A1D-B9F7-5299CBED9EA5

Q57767529-4FB184B7-E471-425E-B8E6-C4CFBE9D655B

Q57767529-7687B2D3-1383-46A8-B4D6-726071E7A046

Q57767529-8857EE89-BC64-4EBB-8C4E-0307CEFFE92A

Q57767529-9EAD556D-2ECC-42D7-ADCA-C35DE3790976

Q57767529-D061B005-C520-4EE7-91F5-5C2E4C829773

P2860

Q57767529-0228150B-8A7D-44D1-AADD-D532D47C243C

Q57767529-201042DE-E1B9-44B8-A95A-09DF50A1C3CA

Q57767529-2CD570C7-AEF2-4133-AB54-B897D6D1B312

Q57767529-46BC3D7A-59B7-400E-AA82-B7D95D63CBB9

Q57767529-4B27ACB4-8D01-40A6-BC15-70F7F4A8C0CA

Q57767529-4FC6FD06-5BED-41AA-8844-3B390413BCD6

Q57767529-A1173726-84D7-40A8-959A-9893322E83E5

Q57767529-A364BBB5-D5AA-4EDA-B9A8-D96FDE2D503E

Q57767529-B4F9D4D7-D430-45E3-9B20-D27534154F9E

Q57767529-C23CB8E9-D750-491F-88F8-9C418C8C9B68

P2888

Q57767529-F60ECE8C-BEB7-42EA-AA33-B59D4E18EFEF

P304

Q57767529-1DFE532D-42FE-40A2-B026-B4FF6BAEB781

P31

Q57767529-EBC7211E-AB50-48D0-9869-0DB403885CC8

P356

Q57767529-C02F2F1E-66DE-438E-BD2B-177866EE9E92

P433

Q57767529-77F65918-9366-46D9-A9CC-E65AFB43E2DF

P478

Q57767529-7EA7C90C-96BC-4CB8-B364-B359735F0619

P50

Q57767529-22F3849B-D7F9-48C2-8242-8E37ED9DBAE9

Q57767529-854705C3-34DD-40E2-B13C-992158F23365

Q57767529-CB69CC8D-394B-4A0B-8528-0D03CE4E1C9A

P577

Q57767529-9ED290FD-6C28-43D9-88CD-ADD1FF376AD9

P698

Q57767529-22AD9C2A-513E-4858-B59B-DBC8ACBC7FB1

P356

S00259-012-2061-8

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Comparison of 3'-deoxy-3'-[¹⁸F ...... rization of pancreatic tumours

@en

P2093

A J Beer

http://www.w3.org/2001/XMLSchema#string

H Friess

http://www.w3.org/2001/XMLSchema#string

H J Wester

http://www.w3.org/2001/XMLSchema#string

J T Siveke

http://www.w3.org/2001/XMLSchema#string

K Herrmann

http://www.w3.org/2001/XMLSchema#string

M Dobritz

http://www.w3.org/2001/XMLSchema#string

M Erkan

http://www.w3.org/2001/XMLSchema#string

R M Schmid

http://www.w3.org/2001/XMLSchema#string

T Schuster

http://www.w3.org/2001/XMLSchema#string

P2860

Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.

Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer.

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.

In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography

Pancreatitis associated with pancreatic carcinoma. Preoperative diagnosis: role of CT imaging in detection and evaluation.

Clinical relevance of imaging proliferative activity in lung nodules.

In vivo characterization of proliferation for discriminating cancer from pancreatic pseudotumors.

Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

P2888

s00259-012-2061-8

P304

846-851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-012-2061-8

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Andreas K. Buck

Markus Schwaiger

P577

2012-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22278320

http://www.w3.org/2001/XMLSchema#string